Streetbeat News

AVCRF

Avricore Health Inc.

http://www.axmininc.com/

CEO

Lucy Yan

Industry

Pharmaceutical Preparation Manufacturing

Open

0.05

Mkt cap

Volume

27K

High

0.05

P/E Ratio

-4.94

52-wk high

0.25

Low

0.05

Div yield

N/A

52-wk low

0.04

Avricore Health Inc. is shifting its strategic focus towards the UK healthcare market, moving away from its Canadian partnership with Shoppers Drug Mart. This decision aligns with the UCL Partners' rapid cholesterol initiative in London.

Portfolio Pulse from

November 14, 2024 | 11:15 pm

Avricore Health Inc. has been recognized in Deloitte's 2024 Technology Fast 50™ Companies to Watch, securing the 8th position with a growth rate of 2738%. This highlights their success in pharmacy-based health technology solutions.

Portfolio Pulse from

November 06, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.